secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2025-03-07T23:59:59+00:00
Accession:  0001140361-25-007658
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences stockholders approve share issuance and amended equity plan
-----------------------------------------------------------------------------

- Approved issuance of common stock upon conversion of Series A preferred and exercise of warrants (2,442,111 for, 125,063 against).
- Approved Amended and Restated 2022 Equity Incentive Plan (2,196,615 for, 371,748 against).
- Approved adjournment to solicit additional proxies if needed (2,258,129 for).
- Equity plan adds 4,816,434 shares plus annual 5% evergreen increase through 2034.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000114036125007658/0001140361-25-007658-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000114036125007658/ef20045105_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-25-007658

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer